« Regulatory Science to 2025 » strategy

26 juin 2019

BlueRegWatch

The European Medicines Agency's (EMA) draft 'Regulatory Science to 2025' strategy is a plan for advancing EMA's engagement with regulatory science over the next five to ten years, covering both human and veterinary medicines. In December 2018, EMA published the draft strategy for a six-month public consultation.
EMA invites stakeholders to send comments by 30 June 2019.

BlueRegWatch

Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :

Découvrez notre dernier livre blanc

En savoir plus